Maxime Moniot Selected Research

ibrutinib

1/2021

Cerebral aspergillosis in a patient on ibrutinib therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maxime Moniot Research Topics

Disease

2	Fungemia 01/2023 - 10/2021
2	Aspergillosis 01/2023 - 01/2021
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2023
1	Rheumatoid Arthritis 01/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Fusariosis 09/2022
1	Infections 09/2022
1	Neutropenia 09/2022
1	Hematologic Neoplasms (Hematological Malignancy) 09/2022
1	Pulmonary Aspergillosis 10/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 10/2021
1	Toxoplasmosis 01/2021

Drug/Important Bio-Agent (IBA)

1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	Cell-Free Nucleic AcidsIBA 09/2022
1	DNA (Deoxyribonucleic Acid)IBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	SolutionsIBA 01/2021
1	ibrutinibIBA 01/2021

Therapy/Procedure

1	Organ Transplantation 09/2022
1	Therapeutics 01/2021